Marinol (dronabinol capsules) — Cigna
Anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS)
Preferred products
- generic dronabinol capsules
Initial criteria
- For Marinol (dronabinol capsules): Approve for 6 months if ONE of the following:
- A) Generic dronabinol capsules are requested; OR
- B) If brand Marinol is being requested, the patient meets BOTH of the following:
- i. Patient has tried generic dronabinol capsules; AND
- ii. The Brand product is being requested due to a formulation difference in the inactive ingredient(s) [e.g., difference in dyes, fillers, preservatives] between the Brand and the bioequivalent generic product which, per the prescriber, would result in a significant allergy or serious adverse reaction.
- For Syndros (dronabinol oral solution): Approve for 6 months if ONE of the following:
- A) Patient has tried generic dronabinol capsules; OR
- B) Patient cannot swallow or has difficulty swallowing capsules.
Approval duration
6 months